A new direction in magnetotherapy has developed in recent years, particularly in Russia, on the basis of Russian-manufactured magnetotherapy instruments of the “Magnitoturbotron” type; in this approach, the whole body is exposed to weak low-frequency vortex magnetic fields (VMF). One systemwide VMF magnetotherapy approach is the introduction of this treatment to regimens for the radial and restorative treatment of oncological diseases. In this regard, the effective use of weak low-frequency VMF on the patient’s body requires deeper study of both the local effects of treatment on tumors, but also the systemic reactions of the body as a whole.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sinitskii, D. A., “The Magnitoturbotron magnetotherapeutic apparatus,” RF Patent No. 1588425.
Rybakov, Yu. L., Sedakova, A. A., Nikolaeva, T. G., Meshcherikova, V. V., and Dobrynin Ya. V., “Studies of the antitumor actions of vortex magnetic fields (VMF) in an experimental test system in vitro and in vivo,” Med. Fizika, No. 3, 42-50 (2003).
Bakhmutskii, N. G., Moroz, A. N., Golubtsov, V. I., and Bodnya V. N., “Cellular proliferative activity and apoptosis in various tumors cultured in diffusion chamber in vivo on exposure to vortex magnetic fields,” Kubansk. Nauchn. Med. Vestn., No. 1-2, 155-158 (2005).
Rybakov, Yu. L., Ryabykh, T. P., and Nikolaeva, T. G., “The antitumor efficacy of vortex magnetic fields (VMF). Part 2. Experimental studies of the effects of VMF on the production of reactive oxygen species (ROS) by phagocytes,” Med. Fizika, 17, No. 1, 34-39 (2003).
Rybakov, Yu. L., Ryabykh, T. P., and Nikolaeva, T. G., “The antitumor efficacy of vortex magnetic fields (VMF). Part 3. Studies of the radiomodifying action of VMF in experimental animals,” Med. Fizika, 18, No. 2, 28-32 (2003).
Akhundov, A. A., Nikolaeva, T. G., and Rybakov, Yu. L., “The use of magnetotherapy in the combined treatment of oropharyngeal cancer (preliminary results),” in: Proceedings of the III Congress of Oncologists in the Trancaucasian States [in Russian], Erevan, Armenia (2004), pp. 55-56.
Letyagin, V. P., Protchenko, N. V., Rybakov, Yu. L., and Dobrynin Ya. V. “Experience in the use of vortex magnetic fields in the treatment of breast cancer,” Vopr. Onkol., 49, No. 6, 120-124 (2003).
Rybakov, Yu. L., Letyagin, V. P., and Protchenko, N. V., “The antitumor efficacy of vortex magnetic fields (VMP). Part 4. The use of VMF in the treatment of breast cancer in humans,” Med. Fizika, 18, No. 2, 33-38 (2003).
The Madin Group. https://www.madin.ru
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Meditsinskaya Tekhnika, Vol. 51, No. 5, Sep.-Oct., 2017, pp. 52-55.
Rights and permissions
About this article
Cite this article
Rybakov, Y.L., Gukasov, V.M., Gudkov, A.G. et al. Low-Energy Complex Magnetotherapy in Oncology. Biomed Eng 51, 373–375 (2018). https://doi.org/10.1007/s10527-018-9751-x
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10527-018-9751-x